STRONG MEMORIAL HOSPITAL
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $185.1M
- Transactions
- 10,816
- Companies
- 40
- Average per transaction
- $17,115
Who reported the payments
| AstraZeneca | $46,471,592 |
| Pfizer | $18,490,271 |
| Gilead | $14,115,488 |
| Merck | $12,904,421 |
| Biogen | $10,713,849 |
| Clerio Vision, Inc | $6,359,260 |
| Eli Lilly | $4,905,216 |
| Genentech, Inc. | $4,678,737 |
| Janssen Research & Development, LLC | $3,745,351 |
| Sarepta Therapeutics, Inc. | $3,260,390 |
| Bristol Myers Squibb | $2,835,043 |
| Boston Scientific | $2,455,490 |
| Tesaro, Inc. | $2,306,749 |
| United Therapeutics Corporation | $2,204,054 |
| Seagen Inc. | $2,078,698 |
| Intuitive Surgical | $1,970,315 |
| Abbott | $1,806,348 |
| GRT US Holding, Inc. | $1,765,668 |
| Novartis | $1,733,590 |
| Astrazeneca UK Limited | $1,692,713 |
| Neurocrine Biosciences, Inc. | $1,649,329 |
| Medtronic | $1,588,229 |
| Eisai Inc. | $1,523,447 |
| AbbVie | $1,410,017 |
| Vertex | $1,347,031 |
| Incyte Corporation | $1,284,258 |
| Regeneron | $1,261,325 |
| Modernatx, Inc. | $1,182,311 |
| E.r. Squibb & Sons, L.L.C. | $1,154,816 |
| Sanofi Pasteur Inc. | $1,130,162 |
| Ortho-clinical Diagnostics, Inc. | $995,190 |
| Roche TCRC, Inc. | $886,337 |
| Amgen | $862,835 |
| Takeda Pharmaceuticals U.S.A., Inc. | $759,909 |
| LSI Solutions Inc | $714,211 |
| Biotronik Inc. | $701,282 |
| Fresenius USA Marketing, Inc. | $695,454 |
| Roche Molecular Systems, Inc. | $630,862 |
| Ventana Medical Systems, Inc. | $610,038 |
| Pharmacyclics LLC, An Abbvie Company | $565,370 |